InterCure Ltd. (TLV:INCR)
Israel · Delayed Price · Currency is ILS · Price in ILA 359.00
+63.50 (21.49%)
May 29, 2026, 1:51 PM IDT
InterCure Employees
InterCure had 320 employees as of December 31, 2024. The number of employees increased by 50 or 18.52% compared to the previous year.
Employees
320
Change (1Y)
50
Growth (1Y)
18.52%
Revenue / Employee
844.38K ILS
Profits / Employee
-111.59K ILS
Market Cap
196.31M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 320 | 50 | 18.52% |
| Dec 31, 2023 | 270 | -100 | -27.03% |
| Dec 31, 2022 | 370 | 20 | 5.71% |
| Dec 31, 2021 | 350 | 275 | 366.67% |
| Dec 31, 2020 | 75 | 0 | - |
| Sep 30, 2020 | 40 | -35 | -46.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Teva Pharmaceutical Industries | 32,842 |
| Kamada | 462 |
| Rekah Pharmaceutical Industry | 390 |
| Together Pharma | 210 |
| Seach Medical Group | 162 |
| Tikun Olam-Cannbit Pharmaceuticals | 4 |
InterCure News
- 4 weeks ago - InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow - GlobeNewsWire
- 3 months ago - InterCure receives noncompliance notification from Nasdaq - TheFly
- 3 months ago - InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement - GlobeNewsWire
- 3 months ago - InterCure reports preliminary FY25 revenue NIS 265M - TheFly
- 3 months ago - InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million - GlobeNewsWire
- 7 months ago - InterCure, Cannasoul sign strategic investment, collaboration agreements - TheFly
- 7 months ago - InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation - GlobeNewsWire
- 8 months ago - InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow - GlobeNewsWire